Inventor · disambiguated record
Sandra Steiner
Also filed as: STEINER SANDRA · STEINER SANDRA C
16 granted patents·18 pending applications·77 citations·filing 2000–2025
91Inventor score
Files withHOFFMANN LA ROCHE25US HEALTH3ADES EDWIN W1GOVERNMENT OF THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES CT S FOR DISEASE CONTROL AND1LARGE SCALE PROTEOMICS CORP A1
Top patents by PatentIndex Score
34 records- 0196US12209091B2Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancersHOFFMANN LA ROCHE·Filed 2020·Granted Jan 28, 2025·7 cites·30 claims
- 0294US11708354B22-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Jul 25, 2023·3 cites·16 claims
- 0392US12344613B2EGFR inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Jul 1, 2025·3 cites·10 claims
- 0488US7642068B2Multiple-valent opsonophagocytic assay selection panel arrays and uses thereforUS HEALTH·Filed 2006·Granted Jan 5, 2010·24 cites·18 claims
- 0587US10882848B22-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compoundsHOFFMANN LA ROCHE·Filed 2019·Granted Jan 5, 2021·3 cites·15 claims
- 0686US11117890B2Substituted isoindole allosteric EGFR inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Sep 14, 2021·3 cites·21 claims
- 0782US10730881B2Fused pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2019·Granted Aug 4, 2020·2 cites·13 claims
- 0880US7919104B2Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereofUS HEALTH·Filed 2005·Granted Apr 5, 2011·4 cites·6 claims
- 0979US8178547B2Heterocyclic antiviral compoundsSTEINER SANDRA·Filed 2009·Granted May 15, 2012·7 cites·7 claims
- 1078US6815172B1Methods and compositions for opsonophagocytic assaysUS HEALTH·Filed 2000·Granted Nov 9, 2004·20 cites·33 claims
- 1178US2025289824A1Egfr inhibitor for the treatment of cancerHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1273US2024132471A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1372US2022135571A1Therapeutic egfr inhibitorsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1471US12421209B2CompoundsHOFFMANN LA ROCHE·Filed 2025·Granted Sep 23, 2025·0 cites·2 claims
- 1570US2025276958A1CompoundsHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 1669US9101582B2Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogenGOVERNMENT OF THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES CT S FOR DISEASE CONTROL AND·Filed 2013·Granted Aug 11, 2015·1 cites·4 claims
- 1769US8431134B2Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogenADES EDWIN W·Filed 2009·Granted Apr 30, 2013·0 cites·6 claims
- 1865US12479849B2EGFR inhibitors for the treatment of cancerHOFFMANN LA ROCHE·Filed 2020·Granted Nov 25, 2025·0 cites·8 claims
- 1965US2022112199A1Egfr inhibitor for medical useHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2062US2024279237A1Fused bicyclic heteroaryl compounds useful as nlrp3 inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2162US2025313565A1New indazole derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2261US2024409553A1Heterocyclic nlrp3 inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2361US2024308977A1Pyridazine derivatives as inhibitors of nlrp3HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2458US2022315591A1New egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2558US2025353830A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2652US11840528B2Isoxazolyl ether derivatives as GABAA α5 PAMHOFFMANN LA ROCHE·Filed 2020·Granted Dec 12, 2023·0 cites·15 claims
- 2751US10669276B2Fused pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Jun 2, 2020·0 cites·24 claims
- 2851US2022315577A1New egfr inhibitorsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2951US2020308171A1Bifunctional inhibitors with egfr having a e3 ubiquitin ligase moietyHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3051US2020361930A1Bifunctional molecules that degrade egfrHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3148US2010099138A1Multiple-valent opsonophagocytic assay selection panel arrays and uses thereforUS GOV HEALTH & HUMAN SERV·Filed 2009·Application pending·0 cites
- 3242US2006024234A1Protein markers for pharmaceuticals and related toxicityLARGE SCALE PROTEOMICS CORP A·Filed 2005·Application pending·0 cites
- 3340US2015274777A1Ketoamide immunoproteasome inhibitorsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3440US2002072492A1Non-genetic based protein disease markersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sandra Steiner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →